The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic Drug Usage of Brain Tumor: Version 2021.1

Background To date, there has been no practical guidelines for the prescription of antiepileptic drugs (AEDs) in brain tumor patients in Korea. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, had begun preparing guidelines for AED usage in brain tumors since...

Full description

Saved in:
Bibliographic Details
Published in:Brain tumor research and treatment 2021-04, Vol.9 (1), p.9
Main Authors: Jangsup Moon, Min-sung Kim, Young Zoon Kim, Kihwan Hwang, Ji Eun Park, Kyung Hwan Kim, Jin Mo Cho, Wan-soo Yoon, Se Hoon Kim, Young Il Kim, Ho Sung Kim, Yun-sik Dho, Jae-sung Park, Hong In Yoon, Youngbeom Seo, Kyoung Su Sung, Jin Ho Song, Chan Woo Wee, Min Ho Lee, Myung-hoon Han, Je Beom Hong, Jung Ho Im, Se-hoon Lee, Jong Hee Chang, Do Hoon Lim, Chul-kee Park, Youn Soo Lee, Ho-shin Gwak
Format: Article
Language:Korean
Subjects:
Antiepileptic drug
Brain tumors
Guideline
Korean Society for Neuro-Oncology
Practice
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 1
container_start_page 9
container_title Brain tumor research and treatment
container_volume 9
creator Jangsup Moon
Min-sung Kim
Young Zoon Kim
Kihwan Hwang
Ji Eun Park
Kyung Hwan Kim
Jin Mo Cho
Wan-soo Yoon
Se Hoon Kim
Young Il Kim
Ho Sung Kim
Yun-sik Dho
Jae-sung Park
Hong In Yoon
Youngbeom Seo
Kyoung Su Sung
Jin Ho Song
Chan Woo Wee
Min Ho Lee
Myung-hoon Han
Je Beom Hong
Jung Ho Im
Se-hoon Lee
Jong Hee Chang
Do Hoon Lim
Chul-kee Park
Youn Soo Lee
Ho-shin Gwak
description Background To date, there has been no practical guidelines for the prescription of antiepileptic drugs (AEDs) in brain tumor patients in Korea. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, had begun preparing guidelines for AED usage in brain tumors since 2019. Methods The Working Group was composed of 27 multidisciplinary medical experts in Korea. References were identified through searches of PubMed, MEDLINE, EMBASE, and Cochrane CENTRAL using specific and sensitive keywords as well as combinations of the keywords. Results The core contents are as follows. Prophylactic AED administration is not recommended in newly diagnosed brain tumor patients without previous seizure history. When AEDs are administered during peri/postoperative period, it may be tapered off according to the following recommendations. In seizure-naive patients with no postoperative seizure, it is recommended to stop or reduce AED 1 week after surgery. In seizure-naive patients with one early postoperative seizure (
format article
fullrecord <record><control><sourceid>kiss</sourceid><recordid>TN_cdi_kiss_primary_3884043</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><kiss_id>3884043</kiss_id><sourcerecordid>3884043</sourcerecordid><originalsourceid>FETCH-kiss_primary_38840433</originalsourceid><addsrcrecordid>eNp9yrFugzAQgGEPqdSozRN0uTEZiIwBgbI1bdNISDBAu0YWPeilxIfOMPD2kaLOmf7h-xdqaUyWBSbWyaNaeX_WWocmSdI0XSqpfxFyFrQOKm4IxxlaFihwEg5K13DP3QzrvCrKDXxO9IM9Obw9r24kHKjHYaQG3mXq4MvbDoFb2IslB_V0YdnBN4ondmC0Cbfhs3pobe9x9d8n9XL4qN-OwR95fxqELlbmU5RlsY6j6L5eAYNUQwg</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic Drug Usage of Brain Tumor: Version 2021.1</title><source>PubMed Central</source><creator>Jangsup Moon ; Min-sung Kim ; Young Zoon Kim ; Kihwan Hwang ; Ji Eun Park ; Kyung Hwan Kim ; Jin Mo Cho ; Wan-soo Yoon ; Se Hoon Kim ; Young Il Kim ; Ho Sung Kim ; Yun-sik Dho ; Jae-sung Park ; Hong In Yoon ; Youngbeom Seo ; Kyoung Su Sung ; Jin Ho Song ; Chan Woo Wee ; Min Ho Lee ; Myung-hoon Han ; Je Beom Hong ; Jung Ho Im ; Se-hoon Lee ; Jong Hee Chang ; Do Hoon Lim ; Chul-kee Park ; Youn Soo Lee ; Ho-shin Gwak</creator><creatorcontrib>Jangsup Moon ; Min-sung Kim ; Young Zoon Kim ; Kihwan Hwang ; Ji Eun Park ; Kyung Hwan Kim ; Jin Mo Cho ; Wan-soo Yoon ; Se Hoon Kim ; Young Il Kim ; Ho Sung Kim ; Yun-sik Dho ; Jae-sung Park ; Hong In Yoon ; Youngbeom Seo ; Kyoung Su Sung ; Jin Ho Song ; Chan Woo Wee ; Min Ho Lee ; Myung-hoon Han ; Je Beom Hong ; Jung Ho Im ; Se-hoon Lee ; Jong Hee Chang ; Do Hoon Lim ; Chul-kee Park ; Youn Soo Lee ; Ho-shin Gwak</creatorcontrib><description>Background To date, there has been no practical guidelines for the prescription of antiepileptic drugs (AEDs) in brain tumor patients in Korea. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, had begun preparing guidelines for AED usage in brain tumors since 2019. Methods The Working Group was composed of 27 multidisciplinary medical experts in Korea. References were identified through searches of PubMed, MEDLINE, EMBASE, and Cochrane CENTRAL using specific and sensitive keywords as well as combinations of the keywords. Results The core contents are as follows. Prophylactic AED administration is not recommended in newly diagnosed brain tumor patients without previous seizure history. When AEDs are administered during peri/postoperative period, it may be tapered off according to the following recommendations. In seizure-naive patients with no postoperative seizure, it is recommended to stop or reduce AED 1 week after surgery. In seizure-naive patients with one early postoperative seizure (&lt;1 week after surgery), it is advisable to maintain AED for at least 3 months before tapering. In seizure-naive patients with ≥2 postoperative seizures or in patients with preoperative seizure history, it is recommended to maintain AEDs for more than 1 year. The possibility of drug interactions should be considered when selecting AEDs in brain tumor patients. Driving can be allowed in brain tumor patients when proven to be seizure-free for more than 1 year. Conclusion The KSNO suggests prescribing AEDs in patients with brain tumor based on the current guideline. This guideline will contribute to spreading evidence-based prescription of AEDs in brain tumor patients in Korea.</description><identifier>ISSN: 2288-2405</identifier><language>kor</language><publisher>대한뇌종양학회·대한신경종양학회·대한소아뇌종양학회</publisher><subject>Antiepileptic drug ; Brain tumors ; Guideline ; Korean Society for Neuro-Oncology ; Practice</subject><ispartof>Brain tumor research and treatment, 2021-04, Vol.9 (1), p.9</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids></links><search><creatorcontrib>Jangsup Moon</creatorcontrib><creatorcontrib>Min-sung Kim</creatorcontrib><creatorcontrib>Young Zoon Kim</creatorcontrib><creatorcontrib>Kihwan Hwang</creatorcontrib><creatorcontrib>Ji Eun Park</creatorcontrib><creatorcontrib>Kyung Hwan Kim</creatorcontrib><creatorcontrib>Jin Mo Cho</creatorcontrib><creatorcontrib>Wan-soo Yoon</creatorcontrib><creatorcontrib>Se Hoon Kim</creatorcontrib><creatorcontrib>Young Il Kim</creatorcontrib><creatorcontrib>Ho Sung Kim</creatorcontrib><creatorcontrib>Yun-sik Dho</creatorcontrib><creatorcontrib>Jae-sung Park</creatorcontrib><creatorcontrib>Hong In Yoon</creatorcontrib><creatorcontrib>Youngbeom Seo</creatorcontrib><creatorcontrib>Kyoung Su Sung</creatorcontrib><creatorcontrib>Jin Ho Song</creatorcontrib><creatorcontrib>Chan Woo Wee</creatorcontrib><creatorcontrib>Min Ho Lee</creatorcontrib><creatorcontrib>Myung-hoon Han</creatorcontrib><creatorcontrib>Je Beom Hong</creatorcontrib><creatorcontrib>Jung Ho Im</creatorcontrib><creatorcontrib>Se-hoon Lee</creatorcontrib><creatorcontrib>Jong Hee Chang</creatorcontrib><creatorcontrib>Do Hoon Lim</creatorcontrib><creatorcontrib>Chul-kee Park</creatorcontrib><creatorcontrib>Youn Soo Lee</creatorcontrib><creatorcontrib>Ho-shin Gwak</creatorcontrib><title>The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic Drug Usage of Brain Tumor: Version 2021.1</title><title>Brain tumor research and treatment</title><addtitle>Brain Tumor Research and Treatment</addtitle><description>Background To date, there has been no practical guidelines for the prescription of antiepileptic drugs (AEDs) in brain tumor patients in Korea. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, had begun preparing guidelines for AED usage in brain tumors since 2019. Methods The Working Group was composed of 27 multidisciplinary medical experts in Korea. References were identified through searches of PubMed, MEDLINE, EMBASE, and Cochrane CENTRAL using specific and sensitive keywords as well as combinations of the keywords. Results The core contents are as follows. Prophylactic AED administration is not recommended in newly diagnosed brain tumor patients without previous seizure history. When AEDs are administered during peri/postoperative period, it may be tapered off according to the following recommendations. In seizure-naive patients with no postoperative seizure, it is recommended to stop or reduce AED 1 week after surgery. In seizure-naive patients with one early postoperative seizure (&lt;1 week after surgery), it is advisable to maintain AED for at least 3 months before tapering. In seizure-naive patients with ≥2 postoperative seizures or in patients with preoperative seizure history, it is recommended to maintain AEDs for more than 1 year. The possibility of drug interactions should be considered when selecting AEDs in brain tumor patients. Driving can be allowed in brain tumor patients when proven to be seizure-free for more than 1 year. Conclusion The KSNO suggests prescribing AEDs in patients with brain tumor based on the current guideline. This guideline will contribute to spreading evidence-based prescription of AEDs in brain tumor patients in Korea.</description><subject>Antiepileptic drug</subject><subject>Brain tumors</subject><subject>Guideline</subject><subject>Korean Society for Neuro-Oncology</subject><subject>Practice</subject><issn>2288-2405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9yrFugzAQgGEPqdSozRN0uTEZiIwBgbI1bdNISDBAu0YWPeilxIfOMPD2kaLOmf7h-xdqaUyWBSbWyaNaeX_WWocmSdI0XSqpfxFyFrQOKm4IxxlaFihwEg5K13DP3QzrvCrKDXxO9IM9Obw9r24kHKjHYaQG3mXq4MvbDoFb2IslB_V0YdnBN4ondmC0Cbfhs3pobe9x9d8n9XL4qN-OwR95fxqELlbmU5RlsY6j6L5eAYNUQwg</recordid><startdate>20210430</startdate><enddate>20210430</enddate><creator>Jangsup Moon</creator><creator>Min-sung Kim</creator><creator>Young Zoon Kim</creator><creator>Kihwan Hwang</creator><creator>Ji Eun Park</creator><creator>Kyung Hwan Kim</creator><creator>Jin Mo Cho</creator><creator>Wan-soo Yoon</creator><creator>Se Hoon Kim</creator><creator>Young Il Kim</creator><creator>Ho Sung Kim</creator><creator>Yun-sik Dho</creator><creator>Jae-sung Park</creator><creator>Hong In Yoon</creator><creator>Youngbeom Seo</creator><creator>Kyoung Su Sung</creator><creator>Jin Ho Song</creator><creator>Chan Woo Wee</creator><creator>Min Ho Lee</creator><creator>Myung-hoon Han</creator><creator>Je Beom Hong</creator><creator>Jung Ho Im</creator><creator>Se-hoon Lee</creator><creator>Jong Hee Chang</creator><creator>Do Hoon Lim</creator><creator>Chul-kee Park</creator><creator>Youn Soo Lee</creator><creator>Ho-shin Gwak</creator><general>대한뇌종양학회·대한신경종양학회·대한소아뇌종양학회</general><scope>HZB</scope><scope>Q5X</scope></search><sort><creationdate>20210430</creationdate><title>The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic Drug Usage of Brain Tumor: Version 2021.1</title><author>Jangsup Moon ; Min-sung Kim ; Young Zoon Kim ; Kihwan Hwang ; Ji Eun Park ; Kyung Hwan Kim ; Jin Mo Cho ; Wan-soo Yoon ; Se Hoon Kim ; Young Il Kim ; Ho Sung Kim ; Yun-sik Dho ; Jae-sung Park ; Hong In Yoon ; Youngbeom Seo ; Kyoung Su Sung ; Jin Ho Song ; Chan Woo Wee ; Min Ho Lee ; Myung-hoon Han ; Je Beom Hong ; Jung Ho Im ; Se-hoon Lee ; Jong Hee Chang ; Do Hoon Lim ; Chul-kee Park ; Youn Soo Lee ; Ho-shin Gwak</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kiss_primary_38840433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2021</creationdate><topic>Antiepileptic drug</topic><topic>Brain tumors</topic><topic>Guideline</topic><topic>Korean Society for Neuro-Oncology</topic><topic>Practice</topic><toplevel>online_resources</toplevel><creatorcontrib>Jangsup Moon</creatorcontrib><creatorcontrib>Min-sung Kim</creatorcontrib><creatorcontrib>Young Zoon Kim</creatorcontrib><creatorcontrib>Kihwan Hwang</creatorcontrib><creatorcontrib>Ji Eun Park</creatorcontrib><creatorcontrib>Kyung Hwan Kim</creatorcontrib><creatorcontrib>Jin Mo Cho</creatorcontrib><creatorcontrib>Wan-soo Yoon</creatorcontrib><creatorcontrib>Se Hoon Kim</creatorcontrib><creatorcontrib>Young Il Kim</creatorcontrib><creatorcontrib>Ho Sung Kim</creatorcontrib><creatorcontrib>Yun-sik Dho</creatorcontrib><creatorcontrib>Jae-sung Park</creatorcontrib><creatorcontrib>Hong In Yoon</creatorcontrib><creatorcontrib>Youngbeom Seo</creatorcontrib><creatorcontrib>Kyoung Su Sung</creatorcontrib><creatorcontrib>Jin Ho Song</creatorcontrib><creatorcontrib>Chan Woo Wee</creatorcontrib><creatorcontrib>Min Ho Lee</creatorcontrib><creatorcontrib>Myung-hoon Han</creatorcontrib><creatorcontrib>Je Beom Hong</creatorcontrib><creatorcontrib>Jung Ho Im</creatorcontrib><creatorcontrib>Se-hoon Lee</creatorcontrib><creatorcontrib>Jong Hee Chang</creatorcontrib><creatorcontrib>Do Hoon Lim</creatorcontrib><creatorcontrib>Chul-kee Park</creatorcontrib><creatorcontrib>Youn Soo Lee</creatorcontrib><creatorcontrib>Ho-shin Gwak</creatorcontrib><collection>KISS(한국학술정보)</collection><collection>Korean Studies Information Service System (KISS) B-Type</collection><jtitle>Brain tumor research and treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jangsup Moon</au><au>Min-sung Kim</au><au>Young Zoon Kim</au><au>Kihwan Hwang</au><au>Ji Eun Park</au><au>Kyung Hwan Kim</au><au>Jin Mo Cho</au><au>Wan-soo Yoon</au><au>Se Hoon Kim</au><au>Young Il Kim</au><au>Ho Sung Kim</au><au>Yun-sik Dho</au><au>Jae-sung Park</au><au>Hong In Yoon</au><au>Youngbeom Seo</au><au>Kyoung Su Sung</au><au>Jin Ho Song</au><au>Chan Woo Wee</au><au>Min Ho Lee</au><au>Myung-hoon Han</au><au>Je Beom Hong</au><au>Jung Ho Im</au><au>Se-hoon Lee</au><au>Jong Hee Chang</au><au>Do Hoon Lim</au><au>Chul-kee Park</au><au>Youn Soo Lee</au><au>Ho-shin Gwak</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic Drug Usage of Brain Tumor: Version 2021.1</atitle><jtitle>Brain tumor research and treatment</jtitle><addtitle>Brain Tumor Research and Treatment</addtitle><date>2021-04-30</date><risdate>2021</risdate><volume>9</volume><issue>1</issue><spage>9</spage><pages>9-</pages><issn>2288-2405</issn><abstract>Background To date, there has been no practical guidelines for the prescription of antiepileptic drugs (AEDs) in brain tumor patients in Korea. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, had begun preparing guidelines for AED usage in brain tumors since 2019. Methods The Working Group was composed of 27 multidisciplinary medical experts in Korea. References were identified through searches of PubMed, MEDLINE, EMBASE, and Cochrane CENTRAL using specific and sensitive keywords as well as combinations of the keywords. Results The core contents are as follows. Prophylactic AED administration is not recommended in newly diagnosed brain tumor patients without previous seizure history. When AEDs are administered during peri/postoperative period, it may be tapered off according to the following recommendations. In seizure-naive patients with no postoperative seizure, it is recommended to stop or reduce AED 1 week after surgery. In seizure-naive patients with one early postoperative seizure (&lt;1 week after surgery), it is advisable to maintain AED for at least 3 months before tapering. In seizure-naive patients with ≥2 postoperative seizures or in patients with preoperative seizure history, it is recommended to maintain AEDs for more than 1 year. The possibility of drug interactions should be considered when selecting AEDs in brain tumor patients. Driving can be allowed in brain tumor patients when proven to be seizure-free for more than 1 year. Conclusion The KSNO suggests prescribing AEDs in patients with brain tumor based on the current guideline. This guideline will contribute to spreading evidence-based prescription of AEDs in brain tumor patients in Korea.</abstract><pub>대한뇌종양학회·대한신경종양학회·대한소아뇌종양학회</pub><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2288-2405
ispartof Brain tumor research and treatment, 2021-04, Vol.9 (1), p.9
issn 2288-2405
language kor
recordid cdi_kiss_primary_3884043
source PubMed Central
subjects Antiepileptic drug
Brain tumors
Guideline
Korean Society for Neuro-Oncology
Practice
title The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic Drug Usage of Brain Tumor: Version 2021.1
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T13%3A09%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kiss&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Korean%20Society%20for%20Neuro-Oncology%20(KSNO)%20Guideline%20for%20Antiepileptic%20Drug%20Usage%20of%20Brain%20Tumor:%20Version%202021.1&rft.jtitle=Brain%20tumor%20research%20and%20treatment&rft.au=Jangsup%20Moon&rft.date=2021-04-30&rft.volume=9&rft.issue=1&rft.spage=9&rft.pages=9-&rft.issn=2288-2405&rft_id=info:doi/&rft_dat=%3Ckiss%3E3884043%3C/kiss%3E%3Cgrp_id%3Ecdi_FETCH-kiss_primary_38840433%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_kiss_id=3884043&rfr_iscdi=true